Financhill
Back

Madrigal Pharmaceuticals, Inc. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
68

MDGL
Madrigal Pharmaceuticals, Inc.

Last Price:
$547.23
Seasonality Move:
6.56%

7 Day Trial

ALL ACCESS PASS

$ 7

Madrigal Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Madrigal Pharmaceuticals, Inc. has on average historically risen by 47.6% based on the past 19 years of stock performance.
  • Madrigal Pharmaceuticals, Inc. has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%
  • Is Madrigal Pharmaceuticals, Inc. Stock Undervalued?
    The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $546.89. The Score for MDGL is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
  • MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Madrigal Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Madrigal Pharmaceuticals, Inc. has on average historically risen by 47.6% based on the past 19 years of stock performance.

Madrigal Pharmaceuticals, Inc. Stock Rating

Buy
68
Madrigal Pharmaceuticals, Inc. (MDGL) is a Buy

Is Madrigal Pharmaceuticals, Inc. overpriced?

  • Madrigal Pharmaceuticals, Inc. has risen higher in 11 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 57.89%

Madrigal Pharmaceuticals, Inc. Stock Price History

Is MDGL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MDGL is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
madrigalpharma.com

52-Week Data

52-Week High:
615.00
52-Week Low:
265.00

Prediction Charts

Market Cap:
13B
Price in USD:
546.89
Volume:
345K
Beta:
1.05

Technical Analysis

SMA50:
466.78
SMA100:
511.28
SMA200:
446.91
52-Wk Change:
63.45%

Stock Predictions

  • Is Madrigal Pharmaceuticals, Inc. stock public?
    Yes, Madrigal Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Madrigal Pharmaceuticals, Inc. stock quote today?
    The Madrigal Pharmaceuticals, Inc. stock price is 546.89 USD today.
  • How to buy Madrigal Pharmaceuticals, Inc. stock online?
    You can buy Madrigal Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-16 446.84 440.83 455.00 440.00
Mar-17 440.02 443.18 452.20 440.02
Mar-18 440.00 442.00 446.18 427.76
Mar-19 442.64 454.22 460.00 439.68
Mar-20 454.81 441.16 466.90 438.87
Mar-23 447.96 447.72 454.98 442.40
Mar-24 445.00 445.04 449.14 437.05
Mar-25 448.79 461.93 471.72 448.49
Mar-26 457.29 518.76 572.20 455.56
Mar-27 515.70 510.68 523.34 498.03
Mar-30 511.00 505.34 522.00 502.14
Mar-31 514.64 523.47 538.80 510.40
Apr-1 531.32 529.84 545.26 525.00
Apr-2 531.19 546.89 547.98 522.49

Madrigal Pharmaceuticals, Inc. Earnings

Madrigal Pharmaceuticals, Inc. Earnings Report: Per Share Madrigal Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Madrigal Pharmaceuticals, Inc. Forecast Revenue Growth

Madrigal Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Madrigal Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $1.38 per share, a decrease next quarter of $1.40 per share, an increase this year of $5.65 per share, and an increase next year of $18.58 per share.

* Madrigal Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.